WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.65B
(+18%)
Cap. Flow
+$863M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
170
Reduced
126
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
CSX Corp
CSX
$60.6B
| $13.3M | 0.12% |
+358,826
| New | +$13.3M |
|
227
Corning
GLW
$59.8B
| $13.2M | 0.12% |
+401,899
| New | +$13.2M |
|
228
Mersana Therapeutics
MRSN
$34.3M
| $13.1M | 0.12% |
+117,385
| New | +$13.1M |
|
229
Lattice Semiconductor
LSCC
$9.14B
| $13.1M | 0.12% |
167,633
+100,059
| +148% | +$7.83M |
|
230
Dell
DELL
$85B
| $13M | 0.12% |
113,952
-92,532
| -45% | -$10.6M |
|
231
Boston Scientific
BSX
$160B
| $12.8M | 0.12% |
187,296
-278,822
| -60% | -$19.1M |
|
232
EPAM Systems
EPAM
$9.46B
| $12.8M | 0.12% |
+46,272
| New | +$12.8M |
|
233
Paylocity
PCTY
$9.74B
| $12.6M | 0.12% |
+73,464
| New | +$12.6M |
|
|
STKL
234
SunOpta
STKL
$747M
| $12.6M | 0.12% |
1,833,473
-299,265
| -14% | -$2.06M |
|
235
Domino's
DPZ
$15.6B
| $12.2M | 0.11% |
24,525
-5,484
| -18% | -$2.72M |
|
236
Allogene Therapeutics
ALLO
$240M
| $11.8M | 0.11% |
2,633,976
+56,476
| +2% | +$252K |
|
237
Woodward
WWD
$14.7B
| $11.7M | 0.11% |
+76,237
| New | +$11.7M |
|
238
Roper Technologies
ROP
$56.6B
| $11.6M | 0.11% |
+20,607
| New | +$11.6M |
|
239
AnaptysBio
ANAB
$604M
| $11.5M | 0.11% |
508,839
-686,135
| -57% | -$15.5M |
|
240
Spirit AeroSystems
SPR
$4.84B
| $11.4M | 0.11% |
+316,715
| New | +$11.4M |
|
241
GFL Environmental
GFL
$17.8B
| $11.4M | 0.11% |
330,607
+197,120
| +148% | +$6.8M |
|
242
Biohaven
BHVN
$1.68B
| $11.4M | 0.1% |
208,478
-534,637
| -72% | -$29.2M |
|
243
Globe Life
GL
$11.4B
| $11.2M | 0.1% |
+96,224
| New | +$11.2M |
|
244
Mohawk Industries
MHK
$8.32B
| $11.2M | 0.1% |
+85,322
| New | +$11.2M |
|
245
CRISPR Therapeutics
CRSP
$4.71B
| $11.1M | 0.1% |
163,577
+113,544
| +227% | +$7.74M |
|
246
Jasper Therapeutics
JSPR
$42.3M
| $11.1M | 0.1% |
379,246
+205,947
| +119% | +$6.05M |
|
247
Intapp
INTA
$3.67B
| $11.1M | 0.1% |
+322,784
| New | +$11.1M |
|
248
Apellis Pharmaceuticals
APLS
$3.47B
| $11M | 0.1% |
186,998
+774
| +0.4% | +$45.5K |
|
249
Fortune Brands Innovations
FBIN
$7.01B
| $11M | 0.1% |
+129,476
| New | +$11M |
|
250
Hubbell
HUBB
$23B
| $10.9M | 0.1% |
26,226
-82,020
| -76% | -$34M |
|